Milestone Pharmaceuticals Inc. (MIST)
NASDAQ: MIST · Real-Time Price · USD
1.230
0.00 (0.00%)
At close: Jun 8, 2026, 4:00 PM EDT
1.260
+0.030 (2.44%)
After-hours: Jun 8, 2026, 7:15 PM EDT
Milestone Pharmaceuticals Market Cap
Milestone Pharmaceuticals has a market cap or net worth of $167.34 million as of June 8, 2026. Its market cap has increased by 81.38% in one year.
Market Cap
167.34M
Enterprise Value
120.45M
1-Year Change
81.38%
Ranking
Category
Stock Price
$1.23
Market Cap Chart
Since May 9, 2019, Milestone Pharmaceuticals's market cap has decreased from $363.46M to $167.34M, a decrease of -53.96%. That is a compound annual growth rate of -10.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 8, 2026 | 167.34M | -18.45% |
| Dec 31, 2025 | 205.20M | 31.26% |
| Dec 31, 2024 | 156.32M | 117.39% |
| Dec 29, 2023 | 71.91M | -57.49% |
| Dec 30, 2022 | 169.15M | -38.80% |
| Dec 31, 2021 | 276.39M | 38.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tonix Pharmaceuticals Holding | 176.46M |
| Immunic | 173.95M |
| Cartesian Therapeutics | 171.59M |
| Enlivex | 171.14M |
| OnKure Therapeutics | 168.85M |
| Precision BioSciences | 167.71M |
| Innate Pharma | 166.86M |
| Spero Therapeutics | 163.28M |